Viewing Study NCT00446303

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:40 PM
Ignite Modification Date: 2026-01-28 @ 10:34 PM
Study NCT ID: NCT00446303
Status: TERMINATED
Last Update Posted: 2012-01-19
First Post: 2007-03-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase II Study of Maintenance With Azacitidine in MDS Patients
Sponsor: Groupe Francophone des Myelodysplasies
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myelocytic, Acute View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDS View
None Myelodysplastic Syndromes View
None AML View
None Intensive chemotherapy View
None azacitidine View